HLAVNA, Marián, Michal MASAŘÍK, Petr BABULA, Jaromír GUMULEC and Markéta SZTALMACHOVÁ. Lanthanum3+ - A new phosphate chelator used in chronic kidney disease - potents apoptosis in PC-3 and 22Rv1 prostate cancer cell lines and healthy prostate cells PNT1A. In XI. pracovní setkání fyzikálních chemiků a elektrochemiků. 2011. ISBN 978-80-7375-514-0.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Lanthanum3+ - A new phosphate chelator used in chronic kidney disease - potents apoptosis in PC-3 and 22Rv1 prostate cancer cell lines and healthy prostate cells PNT1A
Authors HLAVNA, Marián, Michal MASAŘÍK, Petr BABULA, Jaromír GUMULEC and Markéta SZTALMACHOVÁ.
Edition XI. pracovní setkání fyzikálních chemiků a elektrochemiků, 2011.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
ISBN 978-80-7375-514-0
Changed by Changed by: doc. MUDr. Jaromír Gumulec, Ph.D., učo 185198. Changed: 13/2/2012 18:17.
Abstract
We found that increasing lanthanum concentration caused increasing expression of MT1A in 22Rv1 prostate cancer cell line, but rapid decrement of MT1A expression in PC-3 prostate cancer cell line.
Links
GP301/09/P436, research and development projectName: Analýza metalothioneinu u karcinomu prostaty na úrovni DNA, RNA a proteinu.
Investor: Czech Science Foundation
PrintDisplayed: 15/7/2024 18:55